Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera vs Darbepoetin Alfa in CKD Patients Not on Dialysis
NCT00442702Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2007
- Primary completion
- Aug 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 13
01
Overview
Phase 3, randomised, open-label trial of methoxy polyethylene glycol-epoetin beta in anemia (2 arms), sponsored by Roche. Primary endpoint: Change in Hemoglobin Concentration From Baseline to the Evaluation Period at Month 9. Started Sep 2007; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00442702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442702.